Laboratoire HRA Pharma SAS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Laboratoire HRA Pharma SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011798
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratoire HRA Pharma (HRA Pharma) is a healthcare products provider that offers women’s health and endocrinology products. The company offers a wide range of women’s health products which include emergency contraception, uterine fibroids, regular contraception and genital herp products among others. Its endocrinology products comprise advanced adrenal cortical carcinoma and cushing’s syndrome medicines; and lysosafe service devices. The company operates through partnerships with pharmaceutical companies, public and private institutions, healthcare professionals and others. It operates in France, Germany, Ireland, Italy, Switzerland, Spain, Portugal, Belgium and the UK. HRA Pharma is headquartered in Paris, France.

Laboratoire HRA Pharma SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratoire HRA Pharma SAS, Medical Devices Deals, 2011 to YTD 2017 9
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
HRA Pharma Acquires Compeed from Cilag 11
HRA Pharma Acquires Ovarian Cancer Immunotherapy from Pantarhei Bioscience 12
Venture Financing 13
Embera NeuroTherapeutics Raises USD1.9 Million in Series A-2 Financing 13
Private Equity 14
Astorg Asset Management and Goldman Sachs Acquire Laboratoire HRA Pharma 14
Riverside Acquires Minority Stake in HRA Pharma 16
Partnerships 17
HRA Pharma Enters into Distribution Agreement with Laboratoires Carilene 17
Licensing Agreements 18
ASKA Pharma Enters into Licensing Agreement with HRA Pharma 18
Gedeon Richter Expands Licensing Agreement With HRA Pharma For Esmya 19
Gedeon Richter Expands Licensing Agreement With HRA Pharma 20
ASKA Pharma Enters Into Licensing Agreement With HRA Pharma For ellaOne 21
Asset Transactions 22
Gedeon Richter Acquires Esmya from Laboratoire HRA Pharma 22
Laboratoire HRA Pharma SAS – Key Competitors 23
Laboratoire HRA Pharma SAS – Key Employees 24
Laboratoire HRA Pharma SAS – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Corporate Communications 27
Jul 12, 2016: HRA Pharma Announces CEO Transition to Position Company for the Next Phase of Growth 27
Product News 28
11/21/2016: FIBRISTAL, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment 28
01/20/2016: Depression experts question effectiveness of stress hormone drug 29
Clinical Trials 31
Jan 17, 2017: Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids 31
Oct 17, 2016: Allergan to Present New Data Including Ulipristal Acetate at the American Society of Reproductive Medicine (ASRM) Scientific Congress and Expo in Salt Lake City 33
May 09, 2016: Allergan and Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Key Facts 2
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Laboratoire HRA Pharma SAS, Deals By Therapy Area, 2011 to YTD 2017 8
Laboratoire HRA Pharma SAS, Medical Devices Deals, 2011 to YTD 2017 9
Laboratoire HRA Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
HRA Pharma Acquires Compeed from Cilag 11
HRA Pharma Acquires Ovarian Cancer Immunotherapy from Pantarhei Bioscience 12
Embera NeuroTherapeutics Raises USD1.9 Million in Series A-2 Financing 13
Astorg Asset Management and Goldman Sachs Acquire Laboratoire HRA Pharma 14
Riverside Acquires Minority Stake in HRA Pharma 16
HRA Pharma Enters into Distribution Agreement with Laboratoires Carilene 17
ASKA Pharma Enters into Licensing Agreement with HRA Pharma 18
Gedeon Richter Expands Licensing Agreement With HRA Pharma For Esmya 19
Gedeon Richter Expands Licensing Agreement With HRA Pharma 20
ASKA Pharma Enters Into Licensing Agreement With HRA Pharma For ellaOne 21
Gedeon Richter Acquires Esmya from Laboratoire HRA Pharma 22
Laboratoire HRA Pharma SAS, Key Competitors 23
Laboratoire HRA Pharma SAS, Key Employees 24
Laboratoire HRA Pharma SAS, Other Locations 25
Laboratoire HRA Pharma SAS, Subsidiaries 25

★海外企業調査レポート[Laboratoire HRA Pharma SAS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Salzgitter Klockner-Werke GmbH:企業の戦略・SWOT・財務分析
    SummarySalzgitter Klockner-Werke GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • American Software, Inc. (AMSWA):企業の財務及び戦略的SWOT分析
    Summary American Software, Inc. (ASI) is a software company that develops and provides supply chain management and enterprise software solutions. The company offers products such as American Software's suite of e-business solutions, e-applications, e-intelliprise and flow manufacturing. It services …
  • PNC Wealth Management:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "PNC Wealth Management" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fol …
  • Yes Bank Wealth Management (532648):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Yes Bank Wealth Management" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …
  • Marinus Pharmaceuticals, Inc. (MRNS)(製薬・医療分野):企業M&A動向
    Summary Marinus Pharmaceuticals, Inc. (Marinus) is a pharmaceutical company. The company reformulates, develops and commercializes therapeutics for the treatment of various diseases. It offers therapeutics for the treatment of serious neurological and psychiatric disorders such as epilepsy, posttrau …
  • Greer Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Greer Laboratories Inc (Greer), a subsidiary of Stallergenes Greer plc, is a pharmaceutical company that provides allergy immunotherapy products and services to the healthcare industry. The company provides products in the area of human allergy, veterinary allergy and source materials. It of …
  • Duramed Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Duramed Pharmaceuticals, Inc. M …
  • Medifacts International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Medifacts International, Inc. M …
  • KM Corporation (083550):企業概要、財務及び戦略的SWOT分析
    Summary KM Corporation (KM) is an equipment manufacturer. The company manufactures and markets cast steel made of stainless steel. It conducts businesses through the division that include lost wax, shell casting, sand casting, machinery process, and various surface treatment methods. KM offers produ …
  • CenterPoint Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CenterPoint Energy, Inc. Merger …
  • Novartis AG (NOVN)-製薬・医療分野:企業M&A・提携分析
    Summary Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, n …
  • Node4 Ltd.:企業の戦略・SWOT・財務分析
    SummaryNode4 Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • US Oil Sands Inc. (USO):企業概要、財務及び戦略的SWOT分析
    Summary US Oil Sands Inc. (US Oil Sands), formerly Earth Energy Resources Inc., is an oil and gas company. It focuses on the environmentally sustainable production of heavy oil (bitumen) from surface mineable oil sands. The company has 100% interest in 32,005 acres of leased land in the Uinta Basin …
  • STPandI Public Company Limited:企業の戦略・SWOT・財務分析
    SummarySTPandI Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Uni-President China Holdings Ltd.:戦略・SWOT・企業財務分析
    Uni-President China Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Uni-President China Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Elbit Systems, Ltd.:企業の戦略・SWOT・財務分析
    SummaryElbit Systems, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • China GrenTech Corp. Ltd.の企業概要及び財務/SWOT分析
    China GrenTech Corp. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quart …
  • Astra Otoparts tbk PTの企業概要及び財務/SWOT分析
    Astra Otoparts tbk PT Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly …
  • Boardwalk Pipeline Partners, LP (BWP):企業概要、財務及び戦略的SWOT分析
    Summary Boardwalk Pipeline Partners, LP (Boardwalk Pipeline) is a natural gas service provider. It specializes in offering transportation, storage, gathering and processing of natural gas and liquids. The company, through its subsidiaries operates 14,410 miles of pipelines and underground storage ca …
  • Orchid Orthopedic Solutions LLC-医療機器分野:企業M&A・提携分析
    Summary Orchid Orthopedic Solutions LLC (Orchid Orthopedic) is a medical device company that offers orthopedic and medical device contract design, and manufacturing outsourcing services. The company provides proprietary solutions such as medical device design and development, implant bone in-growth …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆